IMTH
AnTix Holdings, Inc.0.0800
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
4.79MP/E (TTM)
-Basic EPS (TTM)
-0.34Dividend Yield
0%Recent Filings
10-K
8-K
Ticketbash deal restructured, closed
8-K
Secures $77k net funding
Innovative MedTech closed a $85,000 securities purchase agreement with Labrys Fund II on August 6, 2025, issuing a $97,750 convertible note carrying 12% one-time interest. Net proceeds of $77,000 fund business development and working capital, barred from debt repayment or affiliate loans. Note mandates $54,740 payment by February 4, 2026, then monthly $9,123.33; convertible post-default at 71% of recent low bid, capped at 4.99% ownership. Dilution risk looms large.
8-K
Secures $75K notes
Innovative MedTech inked two convertible notes with 1800 Diagonal Lending on June 6, 2025, netting $75,000 after fees for working capital. First note: $66,700 principal at 12% one-time interest, 10 monthly payments of $7,470.40 starting June 30; second: $28,750 principal at 14%, payments from November. Conversion post-default at max($0.01, 71% of 10-day low bid), capped at 4.99% ownership. Dilution risk looms large.
IPO
Employees
Sector
Industry
FCHS
First Choice Healthcare Solutio
0.01+0.00
GCTK
GlucoTrack, Inc.
5.18+0.03
IBO
Impact BioMedical, Inc.
0.44-0.02
INND
Innerscope Hearing Technologies
0.00+0.00
INNV
InnovAge Holding Corp.
5.55-0.27
IRMD
iRadimed Corporation
96.87-0.15
IRME
IR-Med Inc.
0.02-0.01
MASI
Masimo Corporation
134.52-2.88
RMD
ResMed Inc.
247.34-5.73
WHTCF
Well Health Technologies Corp.
2.89+0.03